Researchers examine strains between bone and graft from animal models

For the first time, scientists have been able to study how well synthetic bone grafts stand up to the rigors and 'strains' of life, and how quickly they help bone re-grow and repair.

Researchers led by Dr Gianluca Tozzi, at the University of Portsmouth, are the first to examine the strains between bone and graft from animal models in 3D and in microscopic detail.

Dr Tozzi hopes this window on to living bone grafts will help scientists find ways to improve the body's ability to regrow its own bone, and more chance surgeons can predict the success of a synthetic graft.

Dr Gianluca Tozzi, at the University of Portsmouth:

Every three seconds a person breaks a bone due to increased bone fragility. Fragile bones break easily and are also more difficult to repair, particularly when the defect area is extended. It's vital we understand what is happening where bone meets graft so we can better engineer sophisticated replacement materials.

Bones are very complex biological tissues and a synthetic bone substitute needs to have specific requirements to allow blood supply and encourage new bone growth.

In this sense, the new generation of synthetic grafts have the potential to be resorbed by the body in time, allowing gradual bone regeneration in the defect site. However, biomaterials that degrade too quickly don't allow enough time for the new bone to grow, and grafts that degrade too slowly can cause mechanical instability to the implantation site. It's important to get it right."

Millions of people a year in the UK are given a bone graft. They're commonly used in the spine, hip, knee and ankle. Their role is bridge gaps in a broken bone that are too large for the bone to close on its own. They're also used in dental implants, to help teeth attach to the jawbone.

Some grafts can be made using a fragment of the patient's own bone or other sources, but this is more invasive and can cause adverse reactions. Therefore, it's becoming increasingly common for grafts to be made by synthetic materials, including glass, ceramics and even, in very small joints, plaster of Paris.

Dr Tozzi and colleagues have been using synchrotron X-ray computed tomography (SR-XCT) at the Diamond Light Source and in lab-based systems at the Zeiss Global Centre at the University of Portsmouth to better understand the performance of graft materials and their ability to promote bone healing.

In a recently published study in ACS Biomaterials Science & Engineering, they examined the micromechanics and microdamage evolution of four different bone-biomaterial systems combining high-resolution synchrotron tomography, in situ mechanics and digital volume correlation.

Dr Tozzi said: "It's essential we are able to look at the interface between bone and graft and judge their load-bearing capability in order to understand both biological integration and structural integrity of the intervention.

"By carrying out time-lapse experiments of such constructs, we could observe damage progression and see, for the first time, how strain could be used to understand and potentially predict clinical outcome of biomaterials in a living body, improving our knowledge significantly."

Source:
Journal reference:

Fernandez, M. et al. (2019) Full-Field Strain Analysis of Bone–Biomaterial Systems Produced by the Implantation of Osteoregenerative Biomaterials in an Ovine Model. ACS Biomaterials Science & Engineering. doi.org/10.1021/acsbiomaterials.8b01044

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial finds pomalidomide effective for treating rare bleeding disorder